BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Cheung CS, Lui JC, Baron J. Identification of chondrocyte-binding peptides by phage display. J Orthop Res 2013;31:1053-8. [PMID: 23440926 DOI: 10.1002/jor.22325] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.7] [Reference Citation Analysis]
Number Citing Articles
1 Huang J, Liu Q, Xia J, Chen X, Xiong J, Yang L, Liang Y. Modification of mesenchymal stem cells for cartilage-targeted therapy. J Transl Med 2022;20:515. [DOI: 10.1186/s12967-022-03726-8] [Reference Citation Analysis]
2 Celik B, Cicek K, Leal AF, Tomatsu S. Regulation of Molecular Targets in Osteosarcoma Treatment. IJMS 2022;23:12583. [DOI: 10.3390/ijms232012583] [Reference Citation Analysis]
3 Mehta S, He T, Bajpayee AG. Recent advances in targeted drug delivery for treatment of osteoarthritis. Curr Opin Rheumatol 2021;33:94-109. [PMID: 33229973 DOI: 10.1097/BOR.0000000000000761] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 18.0] [Reference Citation Analysis]
4 Xu P, Ghosh S, Gul AR, Bhamore JR, Park JP, Park TJ. Screening of specific binding peptides using phage-display techniques and their biosensing applications. TrAC Trends in Analytical Chemistry 2021;137:116229. [DOI: 10.1016/j.trac.2021.116229] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
5 Liang Y, Xu X, Xu L, Prasadam I, Duan L, Xiao Y, Xia J. Non-surgical osteoarthritis therapy, intra-articular drug delivery towards clinical applications. J Drug Target 2021;29:609-16. [PMID: 33356642 DOI: 10.1080/1061186X.2020.1870231] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 9.0] [Reference Citation Analysis]
6 McClurg O, Tinson R, Troeberg L. Targeting Cartilage Degradation in Osteoarthritis. Pharmaceuticals (Basel) 2021;14:126. [PMID: 33562742 DOI: 10.3390/ph14020126] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 11.0] [Reference Citation Analysis]
7 Mancipe Castro LM, García AJ, Guldberg RE. Biomaterial strategies for improved intra-articular drug delivery. J Biomed Mater Res A 2021;109:426-36. [PMID: 32780515 DOI: 10.1002/jbm.a.37074] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
8 Vedadghavami A, Zhang C, Bajpayee AG. Overcoming negatively charged tissue barriers: Drug delivery using cationic peptides and proteins. Nano Today 2020;34:100898. [PMID: 32802145 DOI: 10.1016/j.nantod.2020.100898] [Cited by in Crossref: 48] [Cited by in F6Publishing: 40] [Article Influence: 24.0] [Reference Citation Analysis]
9 Nasiri N, Hosseini S, Alini M, Khademhosseini A, Baghaban Eslaminejad M. Targeted cell delivery for articular cartilage regeneration and osteoarthritis treatment. Drug Discovery Today 2019;24:2212-24. [DOI: 10.1016/j.drudis.2019.07.010] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 7.3] [Reference Citation Analysis]
10 Lima AC, Ferreira H, Reis RL, Neves NM. Biodegradable polymers: an update on drug delivery in bone and cartilage diseases. Expert Opinion on Drug Delivery 2019;16:795-813. [DOI: 10.1080/17425247.2019.1635117] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 7.0] [Reference Citation Analysis]
11 Schultz C. Targeting the extracellular matrix for delivery of bioactive molecules to sites of arthritis. Br J Pharmacol 2019;176:26-37. [PMID: 30311636 DOI: 10.1111/bph.14516] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
12 Yang M, Li Y, Huai Y, Wang C, Yi W, Mao C. Evolutionary selection of personalized melanoma cell/tissue dual-homing peptides for guiding bionanofibers to malignant tumors. Chem Commun (Camb) 2018;54:1631-4. [PMID: 29372921 DOI: 10.1039/c7cc09077c] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 5.3] [Reference Citation Analysis]
13 Martins IM, Reis RL, Azevedo HS. Phage Display Technology in Biomaterials Engineering: Progress and Opportunities for Applications in Regenerative Medicine. ACS Chem Biol 2016;11:2962-80. [PMID: 27661443 DOI: 10.1021/acschembio.5b00717] [Cited by in Crossref: 26] [Cited by in F6Publishing: 19] [Article Influence: 4.3] [Reference Citation Analysis]
14 Bottini M, Bhattacharya K, Fadeel B, Magrini A, Bottini N, Rosato N. Nanodrugs to target articular cartilage: An emerging platform for osteoarthritis therapy. Nanomedicine: Nanotechnology, Biology and Medicine 2016;12:255-68. [DOI: 10.1016/j.nano.2015.09.013] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 5.3] [Reference Citation Analysis]
15 Herchenröder O, Reetz J, Pützer BM. Recent Progress in Strategies for Adenovirus Mediated Therapeutic Cell Targeting. Regenerative Medicine - from Protocol to Patient 2016. [DOI: 10.1007/978-3-319-28274-9_2] [Reference Citation Analysis]
16 Cheung CS, Zhu Z, Lui JC, Dimitrov D, Baron J. Human monoclonal antibody fragments targeting matrilin-3 in growth plate cartilage. Pharm Res 2015;32:2439-49. [PMID: 25690340 DOI: 10.1007/s11095-015-1636-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
17 Reetz J, Herchenröder O, Pützer BM. Peptide-based technologies to alter adenoviral vector tropism: ways and means for systemic treatment of cancer. Viruses 2014;6:1540-63. [PMID: 24699364 DOI: 10.3390/v6041540] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.9] [Reference Citation Analysis]